EFFECTS OF HORMONES OF THE HYPOTHALAMIC-PITUITARY-THYROID AXIS ON ACTIVITIES AND CONCENTRATIONS OF PLASMA CLOTTING FACTOR VIII AND VON WILLEBRAND FACTOR IN RATS

被引:0
作者
Negrev, Negrin [1 ]
Nyagolov, Yuri [2 ]
Ivanova, Margarita [1 ]
Radev, Radko [1 ]
机构
[1] Med Univ Varna, Dept Physiol, Varna 9000, Bulgaria
[2] Med Univ Sofia, Dept Physiol, Sofia 1431, Bulgaria
来源
COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES | 2010年 / 63卷 / 06期
关键词
hypothalamic-pituitary-thyroid axis; F VIII; vWF; hypocoagulability; BLOOD-COAGULATION; SUBCLINICAL HYPOTHYROIDISM; FIBRINOLYSIS; HEMOSTASIS; DISEASE;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Effects of the hormones of the hypothalamic-pituitary-thyroid axis on the plasma levels and activities of factor VIII (F VIII) and von Willebrand factor (vWF) are studied on 65 male Wistar rats. Factor VIII: Ag, Factor VIII: C, vWF: Ag, vWF: CB, vWF: Rco activity, activated partial thromboplastine time (aPTT) and prothrombine time (PT) were determined on automatic coagulometer and ELISA reader. Thyreotropin releasing hormone (0.06 mg/kg b.w.), Thyreotropin (1 MU/kg b.w.), Liothyroninum (0.08 mg/kg b.w.), Levothyroxinum (0.08 mg/kg b.w.), applied s.c. for three consecutive days on four different groups of rats, significantly increased antigen levels of F VIII and vWF, but decreased their activities and extended aPTT and PT. These data indicate that each of the hormones applied inflicts significant changes in hemostasis by suppressing the coagulability both via intrinsic and extrinsic pathways and decreasing F VIII and vWF plasma activities.
引用
收藏
页码:917 / 924
页数:8
相关论文
共 20 条
  • [1] Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism
    Chadarevian, R
    Jublanc, C
    Bruckert, E
    Giral, P
    Ankri, A
    Leenhardt, L
    Chaprnan, J
    Turpin, G
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (05) : 398 - 404
  • [2] Colman R W., 2006, Hemostasis and Thrombosis
  • [3] Basic Principles and Clinical Practice, V5th edn, P17
  • [4] Davies H.M. L., 1995, ADV NITROGEN HETEROC, V1, P1, DOI DOI 10.1016/S1521-4478(06)80013-2
  • [5] Erem C, 2003, INT J CLIN PRACT, V57, P78
  • [6] Blood coagulation and fibrinolysis in patients with hyperthyroidism
    Erem, C
    Ersoz, HÖ
    Karti, SS
    Ukinç, K
    Hacihasanoglu, A
    Deger, O
    Telatar, M
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (04) : 345 - 350
  • [7] FAY PJ, 1993, J BIOL CHEM, V268, P17861
  • [8] Gallistl S, 2000, J PEDIATR ENDOCR MET, V13, P1615
  • [9] Global fibrinolytic capacity in patients with subclinical hypothyroidism
    Guldiken, S
    Demir, M
    Turgut, B
    Altun, BU
    Arikan, E
    Kara, M
    [J]. ENDOCRINE JOURNAL, 2005, 52 (03) : 363 - 367
  • [10] Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism
    Gullu, S
    Sav, H
    Kamel, N
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (03) : 355 - 361